HITLAB Team • March 29, 2024
The escalating prevalence of neurological disorders presents a growing challenge for healthcare, particularly in an aging population. Early diagnosis is crucial for effective treatment, but the mildness of initial symptoms and the absence of accessible monitoring tools can result in delays. Additionally, existing biomarkers lack objectivity, detailed insights, and reproducibility, impeding progress in diagnosis, treatment, and drug development.
In an innovative approach, NeuraMetrix has identified a novel digital biomarker for neurological disorders: typing cadence, the distinctive rhythm individuals employ when typing on a keyboard. While initially envisioning keystroke patterns as an authentication tool, Neurametrix developers later discovered its potential as a diagnostic tool. NeuraMetrix employs an algorithm that analyzes typing consistency, correlating these measures with brain diseases to offer precise diagnostic and progression measurements. The platform’s capability to generate disease ‘fingerprints’ holds the promise of significantly enhancing diagnostic accuracy in the fields of neurology and psychiatry.
NeuraMetrix platform provides a user-friendly interface for clinicians and researchers to access typing cadence data from patients or clinical trial participants. Analysis of this data informs the researcher of the present cognitive state and can be compared to past results to detect even subtle changes. These changes, whether positive or negative, can also help study/inform clinicians about drug or treatment efficacy and potential side effects. This data enables them to optimize clinical trials and refine drug development processes. Additionally, NeuraMetrix offers a simplified patient dashboard, granting patients access to their own data for greater involvement in their healthcare journey. The installation of NeuraMetrix TC on a PC of the patient or clinical trial subject records keystroke data during regular typing, without hindering any normal use of the PC.
NeuraMetrix, currently available for PCs only, is planning to develop a mobile application to further broaden its accessibility. Operating seamlessly across different languages and alphabets, the platform places a strong emphasis on data security to address privacy concerns and minimize hacking risks.
Currently, leading neurological and psychiatric research institutions worldwide, such as the University of Ulm, University of Toronto, Lund University, Boston University, and Harvard among others, utilize NeuraMetrix for their research. The company envisions extending its services to physicians and eventually potential patients following regulatory approvals. NeuraMetrix’s mission is to enhance patient care for individuals with neurological diseases or psychiatric disorders by providing physicians with exceptionally precise and accurate measurements of brain health. Patients benefit from gaining a deeper understanding of their brain health, actively engaging in their care through data monitoring, and collaborating with healthcare providers, leading to earlier interventions and more effectively managed treatment plans.
In a collaboration with HITLAB, the NeuraMetrix platform underwent a comprehensive heuristic evaluation, delving into its usability and functionality to ensure an optimal user experience and real-world applicability. While the platform’s inherent promise for easy installation and use holds significant potential for widespread adoption, the evaluation conducted by HITLAB meticulously adhered to established usability standards and industry best practices to evaluate the platform top to bottom. This thorough analysis covered key factors, including learnability, memorability, efficiency, system use errors, and overall user satisfaction. The heuristic evaluation conducted by HITLAB has proven instrumental in identifying various areas for improvement within the NeuraMetrix platform. It uncovered functional gaps and interface ambiguities, providing valuable insights that present exciting opportunities for enhancement. This process, although primarily focused on the researcher’s viewpoint, considered perspectives from patients and clinicians, ensuring a holistic approach to platform refinement.
NeuraMetrix’s potential for the future is substantial, and with the implementation of HITLAB’s recommendations, the platform envisions transforming into more than just a solution for clinical researchers. NeuraMetrix aspires to establish itself as a benchmark for usability in the field of neurological research. By effectively addressing usability challenges and incorporating recommended enhancements, NeuraMetrix aims to deliver a platform that not only meets current industry standards but sets a new gold standard for usability. This pursuit is integral to paving the way for significant advancements in the understanding and treatment of neurological disorders.
About Neurametrix:
NeuraMetrix’ Mission is to support Neurologists and Psychiatrists with an accurate digital biomarker to detect, monitor, and assess the efficacy of a particular treatment for various Neurological diseases and Psychiatric disorders.
Learn more about
